Cargando…
Age reprogramming: cell rejuvenation by partial reprogramming
‘Age reprogramming’ refers to the process by which the molecular and cellular pathways of a cell that are subject to age-related decline are rejuvenated without passage through an embryonic stage. This process differs from the rejuvenation observed in differentiated derivatives of induced pluripoten...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845736/ https://www.ncbi.nlm.nih.gov/pubmed/36383700 http://dx.doi.org/10.1242/dev.200755 |
_version_ | 1784870977700626432 |
---|---|
author | Singh, Prim B. Zhakupova, Assem |
author_facet | Singh, Prim B. Zhakupova, Assem |
author_sort | Singh, Prim B. |
collection | PubMed |
description | ‘Age reprogramming’ refers to the process by which the molecular and cellular pathways of a cell that are subject to age-related decline are rejuvenated without passage through an embryonic stage. This process differs from the rejuvenation observed in differentiated derivatives of induced pluripotent stem cells, which involves passage through an embryonic stage and loss of cellular identity. Accordingly, the study of age reprogramming can provide an understanding of how ageing can be reversed while retaining cellular identity and the specialised function(s) of a cell, which will be of benefit to regenerative medicine. Here, we highlight recent work that has provided a more nuanced understanding of age reprogramming and point to some open questions in the field that might be explored in the future. |
format | Online Article Text |
id | pubmed-9845736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-98457362023-01-27 Age reprogramming: cell rejuvenation by partial reprogramming Singh, Prim B. Zhakupova, Assem Development Spotlight ‘Age reprogramming’ refers to the process by which the molecular and cellular pathways of a cell that are subject to age-related decline are rejuvenated without passage through an embryonic stage. This process differs from the rejuvenation observed in differentiated derivatives of induced pluripotent stem cells, which involves passage through an embryonic stage and loss of cellular identity. Accordingly, the study of age reprogramming can provide an understanding of how ageing can be reversed while retaining cellular identity and the specialised function(s) of a cell, which will be of benefit to regenerative medicine. Here, we highlight recent work that has provided a more nuanced understanding of age reprogramming and point to some open questions in the field that might be explored in the future. The Company of Biologists Ltd 2022-11-16 /pmc/articles/PMC9845736/ /pubmed/36383700 http://dx.doi.org/10.1242/dev.200755 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Spotlight Singh, Prim B. Zhakupova, Assem Age reprogramming: cell rejuvenation by partial reprogramming |
title | Age reprogramming: cell rejuvenation by partial reprogramming |
title_full | Age reprogramming: cell rejuvenation by partial reprogramming |
title_fullStr | Age reprogramming: cell rejuvenation by partial reprogramming |
title_full_unstemmed | Age reprogramming: cell rejuvenation by partial reprogramming |
title_short | Age reprogramming: cell rejuvenation by partial reprogramming |
title_sort | age reprogramming: cell rejuvenation by partial reprogramming |
topic | Spotlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845736/ https://www.ncbi.nlm.nih.gov/pubmed/36383700 http://dx.doi.org/10.1242/dev.200755 |
work_keys_str_mv | AT singhprimb agereprogrammingcellrejuvenationbypartialreprogramming AT zhakupovaassem agereprogrammingcellrejuvenationbypartialreprogramming |